₹291
in ROW primarily because of PFI supply backlog from Gagillapur. ▪ Senn Chemicals AG : Revenue of ₹291 Mn. ▪ EBITDA: EBITDA% is Impacted by higher manpower costs with consolidation of Senn Chemicals AG.
₹2,806
the acquisition of Senn Chemicals AG. ▪ Cash from operations : Healthy cash flow from operations of ₹2,806 Mn. ▪ CAPEX: Spent of ₹1,137 Mn. R&D ▪ R&D expenses stood at ₹678 Mn (5.6% of sales) in Q1 FY26 as
₹1,137
cals AG. ▪ Cash from operations : Healthy cash flow from operations of ₹2,806 Mn. ▪ CAPEX: Spent of ₹1,137 Mn. R&D ▪ R&D expenses stood at ₹678 Mn (5.6% of sales) in Q1 FY26 as compared to ₹665 Mn (5.5%) i
₹678
cash flow from operations of ₹2,806 Mn. ▪ CAPEX: Spent of ₹1,137 Mn. R&D ▪ R&D expenses stood at ₹678 Mn (5.6% of sales) in Q1 FY26 as compared to ₹665 Mn (5.5%) in Q4 FY25. ▪ New R&D facility being
5.6%
w from operations of ₹2,806 Mn. ▪ CAPEX: Spent of ₹1,137 Mn. R&D ▪ R&D expenses stood at ₹678 Mn (5.6% of sales) in Q1 FY26 as compared to ₹665 Mn (5.5%) in Q4 FY25. ▪ New R&D facility being added fo
₹665
Spent of ₹1,137 Mn. R&D ▪ R&D expenses stood at ₹678 Mn (5.6% of sales) in Q1 FY26 as compared to ₹665 Mn (5.5%) in Q4 FY25. ▪ New R&D facility being added for peptide development in IIT, Hyderabad. ▪
5.5%
₹1,137 Mn. R&D ▪ R&D expenses stood at ₹678 Mn (5.6% of sales) in Q1 FY26 as compared to ₹665 Mn (5.5%) in Q4 FY25. ▪ New R&D facility being added for peptide development in IIT, Hyderabad. ▪ Regulat
64.9%
TDA (before exceptional items) % of EBITDA PBT (before exceptional items) PAT % of PAT 7,850 64.9% 2,028 678 2,678 2,467 20.4% 1,704 1,126 9.3% 7,591 63.4% 1,691 665 2,711 2,524 21.1%
20.4%
of EBITDA PBT (before exceptional items) PAT % of PAT 7,850 64.9% 2,028 678 2,678 2,467 20.4% 1,704 1,126 9.3% 7,591 63.4% 1,691 665 2,711 2,524 21.1% 1,668 1,520 12.7% 1% 3% 14
9.3%
ore exceptional items) PAT % of PAT 7,850 64.9% 2,028 678 2,678 2,467 20.4% 1,704 1,126 9.3% 7,591 63.4% 1,691 665 2,711 2,524 21.1% 1,668 1,520 12.7% 1% 3% 148 bps 20% 2% -1%
63.4%
al items) PAT % of PAT 7,850 64.9% 2,028 678 2,678 2,467 20.4% 1,704 1,126 9.3% 7,591 63.4% 1,691 665 2,711 2,524 21.1% 1,668 1,520 12.7% 1% 3% 148 bps 20% 2% -1% -2% -69 bps
21.1%
64.9% 2,028 678 2,678 2,467 20.4% 1,704 1,126 9.3% 7,591 63.4% 1,691 665 2,711 2,524 21.1% 1,668 1,520 12.7% 1% 3% 148 bps 20% 2% -1% -2% -69 bps 2% -26% -339 bps 11,799 6,95